openPR Logo
Press release

Global Microbial Fermentation Technology Market Size was USD 33,956.10 million in 2024 at a CAGR of 5.24% by 2032, Evaluates DelveInsight

11-04-2025 08:39 PM CET | Health & Medicine

Press release from: DelveInsight Business Research

Global Microbial Fermentation Technology Market Size was USD

According to DelveInsight's analysis, The microbial fermentation technology market is experiencing strong growth, largely due to the increasing incidence of chronic illnesses such as cancer and a range of infectious diseases, including HIV, hepatitis B and C, and influenza. The market is also being boosted by the rising need for advanced therapeutic products like cell therapies, monoclonal antibodies, recombinant proteins, and gene therapies. Moreover, progress in synthetic biology and precision fermentation is improving production efficiency, scalability, and product quality, further accelerating adoption. Together with continuous advancements in bioprocessing techniques, these factors are expected to drive notable market expansion throughout the 2025-2032 forecast period.

DelveInsight's "Microbial Fermentation Technology Market Insights, Competitive Landscape and Market Forecast-2032" report provides the current and forecast market outlook, forthcoming device innovation, challenges, market drivers and barriers. The report also covers the major emerging products and key Microbial Fermentation Technology companies actively working in the market.

To know more about why North America is leading the market growth in the Microbial Fermentation Technology market, get a snapshot of the report Microbial Fermentation Technology Market Trends
https://www.delveinsight.com/sample-request/microbial-fermentation-technology-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr

Microbial Fermentation Technology Overview
Microbial fermentation technology is a bioprocess in which microorganisms such as bacteria, yeast, or fungi are used to convert organic materials into useful products. Through controlled fermentation conditions-like temperature, pH, and oxygen levels-these microbes produce enzymes, antibiotics, vaccines, biofuels, amino acids, vitamins, and other industrial or pharmaceutical compounds.
This technology plays a key role in sectors such as biopharmaceuticals, food and beverages, agriculture, bioenergy, and environmental management, enabling large-scale and cost-effective production of biologically derived materials.

DelveInsight Analysis: The microbial fermentation technology market size was valued at USD 33,956.10 million in 2024 and is anticipated to expand at a CAGR of 5.24% over the forecast period from 2025 to 2032.

Microbial Fermentation Technology Market Insights
Geographically, North America is expected to lead the microbial fermentation technology market throughout the 2025-2032 forecast period. This dominance is driven by factors such as the growing incidence of infectious diseases like tuberculosis, influenza, and new emerging pathogens, along with a rising number of cancer cases. In addition, strong R&D activity, the presence of major industry players, and a highly developed healthcare infrastructure further reinforce the region's market leadership.

To read more about the latest highlights related to Microbial Fermentation Technology, get a snapshot of the key highlights entailed in the Microbial Fermentation Technology Insights
https://www.delveinsight.com/report-store/microbial-fermentation-technology-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr

Recent Developments in the Microbial Fermentation Technology Market Report
• In June 2024, Danone, Michelin, DMC Biotechnologies, and Crédit Agricole Centre France collaborated to establish the Biotech Open Platform, a cutting-edge biotechnology hub aimed at advancing large-scale precision fermentation. This initiative enhanced the development of bio-based materials and ingredients by leveraging advanced microbial fermentation processes.
• In March 2024, Novel Bio, a leader in next-generation biomanufacturing technologies for plasmid DNA in genetic medicines, announced a partnership with Culture Biosciences to advance scalable fermentation process development for its proprietary NBx PlatformTM.
• Thus, owing to such developments in the market, rapid growth will be observed in the Microbial Fermentation Technology market during the forecast period

Key Players in the Microbial Fermentation Technology Market
Some of the key market players operating in the Microbial Fermentation Technology market include- Novozymes A/S, Lonza Group AG, Koninklijke DSM N.V., Biocon Limited, Ajinomoto Co., Inc., Evonik Industries AG, Intralytix, Inc., UAS Laboratories LLC, Second Genome, Inc., Chr. Hansen Holding A/S, Ginkgo Bioworks, Amyris, Inc., Lesaffre, BioVectra Inc.TerraVia Holdings, Inc., and others.

Which MedTech key players in the Microbial Fermentation Technology market are set to emerge as the trendsetter explore @ Key Microbial Fermentation Technology Companies
https://www.delveinsight.com/sample-request/microbial-fermentation-technology-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr

Analysis on the Microbial Fermentation Technology Market Landscape
Global health organizations and regulatory agencies are increasingly contributing to the growth of the antibiotics market. Groups such as the Global Antibiotic Research & Development Partnership (GARDP), the U.S. Biomedical Advanced Research and Development Authority (BARDA), and the European Innovative Medicines Initiative (IMI) are investing in and supporting antibiotic research and development. These initiatives are essential for tackling the growing threat of antimicrobial resistance (AMR) and ensuring access to effective treatments.
With the combined impact of rising infectious disease rates, escalating AMR concerns, ongoing technological progress, and strong governmental and institutional support, the antibiotics segment is expected to witness substantial growth. This momentum will play a key role in driving the expansion of the overall microbial fermentation technology market throughout the 2025-2032 forecast period.

Scope of the Microbial Fermentation Technology Market Report
• Coverage: Global
• Study Period: 2022-2032
• Microbial Fermentation Technology Market Segmentation By Product Type: Antibiotics, Probiotics, Monoclonal Antibodies, Biosimilar, Recombinant Proteins & Vaccines, Enzymes, and Others
• Microbial Fermentation Technology Market Segmentation By End-User: Pharmaceutical & Biotechnology Industry, Contract Research Organizations (CROs), CMOs & CDMOs, and Academic & Research Institutions
• Microbial Fermentation Technology Market Segmentation By Geography: North America, Europe, Asia-Pacific, and Rest of the World
• Key Microbial Fermentation Technology Companies: Novozymes A/S, Lonza Group AG, Koninklijke DSM N.V., Biocon Limited, Ajinomoto Co., Inc., Evonik Industries AG, Intralytix, Inc., UAS Laboratories LLC, Second Genome, Inc., Chr. Hansen Holding A/S, Ginkgo Bioworks, Amyris, Inc., Lesaffre, BioVectra Inc.TerraVia Holdings, Inc., and others
• Porter's Five Forces Analysis, Product Profiles, Case Studies, KOL's Views, Analyst's View

Interested in knowing how the Microbial Fermentation Technology market will grow by 2032? Click to get a snapshot of the Microbial Fermentation Technology Market Analysis
https://www.delveinsight.com/sample-request/microbial-fermentation-technology-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr

Contact Us
Gaurav Bora
info@delveinsight.com
+14699457679
www.delveinsight.com

About DelveInsight
DelveInsight is a leading Business Consultant and Market Research firm focused exclusively on life sciences. It supports Pharma companies by providing end-to-end comprehensive solutions to improve their performance.
Get hassle-free access to all the healthcare and pharma market research reports through our subscription-based platform PharmDelve.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Global Microbial Fermentation Technology Market Size was USD 33,956.10 million in 2024 at a CAGR of 5.24% by 2032, Evaluates DelveInsight here

News-ID: 4253732 • Views:

More Releases from DelveInsight Business Research

Global Patient Engagement Solutions Market to reach USD 59,499.28 million by 2034 at a CAGR of 12.15% by 2032, Evaluates DelveInsight
Global Patient Engagement Solutions Market to reach USD 59,499.28 million by 203 …
According to DelveInsight's analysis, The growth of the patient engagement solutions market is primarily fueled by several major factors, including the increasing burden of chronic conditions such as diabetes and cardiovascular diseases, which require continuous patient involvement and monitoring. The industry is further propelled by the move toward patient-centric healthcare models, ongoing technological innovations, and the introduction of new digital tools and platforms. Moreover, supportive government policies and initiatives aimed
Global Magnetic Resonance Imaging Devices Market to reach USD 13,553.33 million by 2032 at a CAGR of 6.54% by 2032, Evaluates DelveInsight
Global Magnetic Resonance Imaging Devices Market to reach USD 13,553.33 million …
According to DelveInsight's analysis, The growing incidence of chronic illnesses-including heart disease, cancer, and neurological disorders is driving demand for advanced diagnostic methods such as MRI, which provides highly detailed imaging of soft tissues and internal organs. Increasing awareness and a stronger focus on early disease detection are also prompting both patients and healthcare professionals to rely on MRI for faster and more accurate diagnosis. In addition, ongoing technological progress
Global Surgical Robotic System Market to reach USD 29,785.13 million by 2032 at a CAGR of 13.21% by 2032, Evaluates DelveInsight
Global Surgical Robotic System Market to reach USD 29,785.13 million by 2032 at …
According to DelveInsight's analysis, The growing prevalence of chronic illnesses such as cancer, cardiovascular diseases, and orthopedic disorders is driving demand for advanced surgical solutions, which in turn is accelerating the expansion of the surgical robotic systems market. Since many of these conditions require complex, highly precise procedures, robotic-assisted surgery is becoming a preferred option due to its superior precision, less invasive nature, and faster patient recovery. At the same
Global Renal Denervation Devices Market to grow at a CAGR of 14.34% by 2032, Evaluates DelveInsight
Global Renal Denervation Devices Market to grow at a CAGR of 14.34% by 2032, Eva …
According to DelveInsight's analysis, The increasing number of hypertension cases and the rising burden of cardiovascular diseases associated with uncontrolled blood pressure are major factors boosting the demand for renal denervation devices. Their use is also expanding beyond hypertension into additional therapeutic areas, including heart failure and chronic kidney disease, which is widening their market scope. Moreover, ongoing technological improvements and active product development efforts by leading companies worldwide are

All 5 Releases


More Releases for Microbial

Microbial Contamination Identification Market Size Analysis by Application, Type …
According to Market Research Intellect, the global Microbial Contamination Identification market under the Aerospace and Defense category is expected to register notable growth from 2025 to 2032. Key drivers such as advancing technologies, changing consumer behavior, and evolving market dynamics are poised to shape the trajectory of this market throughout the forecast period. The market for microbial contamination identification is expanding steadily due to growing concerns about product safety in industries
Major Market Shift in Microbial Identification Industry: Automated Systems Trans …
What Is the Forecasted Market Size and Growth Rate for the Microbial Identification Market? In the last few years, the size of the microbial identification market has seen significant expansion. It is projected to rise from $5.57 billion in 2024 to $6.44 billion in 2025, with a compound annual growth rate (CAGR) of 15.7%. The exponential growth during the historic period is credited to initiatives and funding from the government which
Microbial Food Ingredient Market Harvesting the Power of Microbes: The Booming M …
Microbial Food Ingredient Market Worth 4.97 Bn 2031- Exclusive Report by InsightAce Analytic Pvt. Ltd. InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Microbial Food Ingredient Market"- By Microorganism (Bacteria, Yeast, Mold), Product Type (Starter Cultures, Protective Cultures, Probiotic Cultures), Strain (Single-Strain Culture, Multi-Strain Culture, Multi-Strain Mixed Culture) End User (Food and Beverage Manufacturers, Animal Feed Additives), Industry Trends, and Global Forecasts, 2022-2035 And
Microbial Identification Market: Unraveling Microbial Mysteries on the Path to U …
The global microbial identification market is expected to be worth US$ 3.7 billion in 2022, and to grow at a CAGR of 11.3% between 2022 and 2032, to be worth around US$ 10.7 billion by 2032. Rising demand for microbial identification products across various end-user sectors such as pharmaceutical and biotechnology, food and beverage, water and environment, diagnostic laboratories, and independent research laboratories is driving the microbial identification market. Based on
Microbial Fermentation Technology Market
According to the report, the global microbial fermentation technology market was valued at US$1,493.8 bn in 2016 and is projected to expand at a CAGR of 5.7% from 2017 to 2025, rising to a valuation of US$2,447.5 bn in 2025. Market Definition: When fungus and other microbes create secondary metabolites, microbial fermentation takes place. When the conditions are ideal, these bacteria may convert affordable nitrogen and carbon sources into crucial intermediates or
Microbial Bioreactor Market
The Global Microbial Bioreactor Market is expected to grow at a CAGR of 20.1% during the forecasting period (2022-2029). Micro bioreactors serve as a multitude of scale-down needs for bioprocesses based on mammalian cells. Microbioreactor technology has allowed for rapid advancements in biotechnology process development and investigation of various biological systems from industrial biotechnology and pharmaceutical biotechnology. Micro bioreactors range in complexity from simple micro-tier-based systems to complex automated parallel bioreactors